Clarity Pharmaceuticals Ltd.ASX: CU6

US FDA Study May Proceed letter for Cu-64 SAR-bisPSMA

Feb 7, 2022 at 4:05 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment